Ryohei Sekimoto

864 citations
13 papers · 678 indexed · h-index 10
Topics
Adipokines, Inflammation, and Metabolic Diseases (9 papers)Adipose Tissue and Metabolism (7 papers)Biomarkers in Disease Mechanisms (5 papers)
Partner nations
JapanUnited States

In The Last Decade

Ryohei Sekimoto

13 papers receiving 662 citations

Peers

Ryohei Sekimoto
Comparison fields: 5 of 86
  • Epidemiology 305
  • Molecular Biology 221
  • Nephrology 220
  • Physiology 178
  • Pathology and Forensic Medicine 124
Replace Yu Tsushima with:
Yu Tsushima Japan
Neerupma Silswal United States
Yuelan Ren United States
Jianqiu Gu China
Miao Yang China
Marcelo Heinig United States
Masako Baba Japan
Mizuki Tani Japan
Sevsen Kulaksızoğlu Türkiye
Fone‐Ching Hsiao Taiwan
Ryohei Sekimoto relative to Yu Tsushima Japan Yu Tsushima's profile →
Citations per field
00.5×1.5×
Yu Tsushima · 1×
Citations per year

Countries citing papers authored by Ryohei Sekimoto

Since Specialization
Citations

This map shows the geographic impact of Ryohei Sekimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryohei Sekimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryohei Sekimoto more than expected).

Fields of papers citing papers by Ryohei Sekimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryohei Sekimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryohei Sekimoto. The network helps show where Ryohei Sekimoto may publish in the future.

Co-authorship network of co-authors of Ryohei Sekimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryohei Sekimoto. A scholar is included among the top collaborators of Ryohei Sekimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryohei Sekimoto. Ryohei Sekimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 2
2 96
3 42
4 9
5 14
6 6
7 23
8 83
9 7
10 37
11 14
12 299
13 46

About Ryohei Sekimoto

Ryohei Sekimoto is a scholar working on Epidemiology, Physiology and Immunology, having authored 13 papers that have together received 678 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (9 papers), Adipose Tissue and Metabolism (7 papers) and Biomarkers in Disease Mechanisms (5 papers). The work is most often cited by research in Nephrology (220 citations), Epidemiology (305 citations) and Pathology and Forensic Medicine (124 citations). Ryohei Sekimoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Tohru Funahashi, Iichiro Shimomura, Hitoshi Nishizawa, Norikazu Maeda, Hideaki Nakatsuji, Yu Tsushima, Keisuke Matsuda, Takashi Shirakura, Hiroyuki Takahashi and Mizuho Tamura. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026